SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
LIPO-Liposome
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
900 16 0 LIPO
Emcee:  Ming Wu Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
100 I would greatly appreciate any and all help in finding research firms that emPerry-4/2/1997
99 You're right about Abelcet beating out other lipo-amphotericin drugs, at lePathman-3/30/1997
98 Today Sequus announced 1st Q sales will be less than 4th Q sales and the stock John Kwiatkowski-3/27/1997
97 It looks like Albecet is doing pretty well; let's hope that Ventus will paRichL-3/26/1997
96 I don't think Lind has started coverage of anything yet at Morgan. I know Michael Young-3/23/1997
95 Story may be viewed on AOL KEYWORD: IBD New America Section or spend the money John Kwiatkowski-3/22/1997
94 LIPO is featured in this Monday's Investor's Business Daily's New ARidemhigher-3/22/1997
93 These are good points about Lind. My question is "Has he started coverage John Kwiatkowski-3/19/1997
92 David, One possible reason for the delay is that Morgan is sitting on him. WhMeridian-3/19/1997
91 Your comments regarding Doug Lind are well taken. He also was a huge supporterDavid Lefkowitz-3/18/1997
90 John, Your interpretation sounds good. Morgan did buy Dean Witter for its rMeridian-3/17/1997
89 Doug Lind, biotech anlayst at Paine Webber, left P.W. this week and is now witJohn Kwiatkowski-3/12/1997
88 John, Thanks for the clarification. The France approval is good news. AppareMeridian-3/4/1997
87 John, This message is not really directed to you in particular, but feel free (no name provided)-3/3/1997
86 The suit you refer to is a counterclaim to LIPO's patent infringement suit John Kwiatkowski-3/3/1997
85 The stock has been weak in the last 5 days - down about 20%. Some of it could Meridian-2/27/1997
84 Thanks, I spoke to Cheri today. She said that Ostro's report is a few monNeal davidson-2/19/1997
83 Call Cheri Duffy at (609) 452-7060. She is the IR manager at LIPO and will seMichael Young-2/18/1997
82 Can you print Dr. Ostro's report. If not, can you tell us how we can accesNeal davidson-2/18/1997
81 No joke. UBS's biotech analyst Marc Ostro, Ph.D, estimates $5.94/share in Meridian-2/18/1997
80 BOOM! Up $1 3/4 in the last 20 minutes! Heavy volume. Cover ye shorts, run fMeridian-2/18/1997
79 I own 2 Biotech stocks and I am doing verry well with them LIPO,ALKS. ALKS was Pierre-Yves Loriers-2/15/1997
78 Strong, Strong Buying in the last 15-20 minutes of trading! LIPO spent most ofMeridian-2/10/1997
77 I red in the Edgar database that the Alger fund owns over 5% of lipo, any commePierre-Yves Loriers-2/10/1997
76 If they dosed the last patient in April I would think the trials wouldn't aJohn Kwiatkowski-2/9/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News